Feeley Kevin's most recent trade in GeneDx Holdings Corp - Ordinary Shares - Class A was a trade of 7,197 Restricted Stock Unit done . Disclosure was reported to the exchange on June 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2026 | 7,197 | 21,590 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2026 | 7,197 | 43,683 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 60.83 per share. | 16 Jun 2026 | 2,106 | 40,817 | - | 60.8 | 128,106 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 61.50 per share. | 16 Jun 2026 | 863 | 39,954 | - | 61.5 | 53,078 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 59.75 per share. | 16 Jun 2026 | 760 | 42,923 | - | 59.8 | 45,413 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2026 | 2,462 | 37,752 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2026 | 2,462 | 4,925 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 53.77 per share. | 09 Jun 2026 | 1,266 | 36,486 | - | 53.8 | 68,073 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2026 | 717 | 717 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2026 | 717 | 35,659 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 51.74 per share. | 01 Jun 2026 | 369 | 35,290 | - | 51.7 | 19,092 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2026 | 754 | 35,334 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2026 | 754 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 65.19 per share. | 29 Apr 2026 | 392 | 34,942 | - | 65.2 | 25,555 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2026 | 16,250 | 43,398 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2026 | 16,250 | 32,500 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 63.28 per share. | 26 Mar 2026 | 2,520 | 37,432 | - | 63.3 | 159,463 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 61.29 per share. | 26 Mar 2026 | 2,485 | 40,913 | - | 61.3 | 152,308 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 65.21 per share. | 26 Mar 2026 | 1,857 | 34,580 | - | 65.2 | 121,103 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 64.60 per share. | 26 Mar 2026 | 995 | 36,437 | - | 64.6 | 64,276 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 62.33 per share. | 26 Mar 2026 | 961 | 39,952 | - | 62.3 | 59,901 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 7,197 | 32,854 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 7,197 | 28,787 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 3,815 | 11,446 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 3,815 | 25,657 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 77.05 per share. | 15 Mar 2026 | 3,065 | 27,405 | - | 77.0 | 236,157 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 76.35 per share. | 15 Mar 2026 | 2,384 | 30,470 | - | 76.3 | 182,016 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 77.93 per share. | 15 Mar 2026 | 257 | 27,148 | - | 77.9 | 20,029 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2026 | 2,462 | 23,122 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2026 | 2,462 | 7,387 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 86.75 per share. | 09 Mar 2026 | 1,280 | 21,842 | - | 86.8 | 111,045 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 88.11 per share. | 06 Mar 2026 | 1,986 | 20,660 | - | 88.1 | 174,986 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2026 | 15,262 | 24,861 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2026 | 10,865 | 10,865 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 78.61 per share. | 03 Mar 2026 | 2,543 | 20,894 | - | 78.6 | 199,897 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 79.25 per share. | 03 Mar 2026 | 2,220 | 18,674 | - | 79.2 | 175,933 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 77.63 per share. | 03 Mar 2026 | 1,424 | 23,437 | - | 77.6 | 110,540 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 718 | 9,886 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 718 | 1,434 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 77.52 per share. | 01 Mar 2026 | 287 | 9,599 | - | 77.5 | 22,248 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2026 | 754 | 9,485 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2026 | 754 | 754 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 94.00 per share. | 29 Jan 2026 | 315 | 9,170 | - | 94 | 29,610 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 92.00 per share. | 29 Jan 2026 | 2 | 9,168 | - | 92 | 184 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2025 | 7,197 | 12,586 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2025 | 7,197 | 35,984 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 141.21 per share. | 16 Dec 2025 | 951 | 11,138 | - | 141.2 | 134,286 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 146.93 per share. | 16 Dec 2025 | 699 | 9,312 | - | 146.9 | 102,703 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 145.36 per share. | 16 Dec 2025 | 578 | 10,011 | - | 145.4 | 84,016 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 140.08 per share. | 16 Dec 2025 | 366 | 12,089 | - | 140.1 | 51,270 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 144.27 per share. | 16 Dec 2025 | 334 | 10,589 | - | 144.3 | 48,187 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 148.55 per share. | 16 Dec 2025 | 331 | 8,981 | - | 148.5 | 49,170 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 142.12 per share. | 16 Dec 2025 | 215 | 10,923 | - | 142.1 | 30,556 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 138.93 per share. | 16 Dec 2025 | 131 | 12,455 | - | 138.9 | 18,200 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 140.45 per share. | 16 Dec 2025 | 127 | 8,731 | - | 140.4 | 17,837 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 149.20 per share. | 16 Dec 2025 | 97 | 8,884 | - | 149.2 | 14,472 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 150.77 per share. | 16 Dec 2025 | 26 | 8,858 | - | 150.8 | 3,920 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2025 | 2,462 | 9,849 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2025 | 2,462 | 6,655 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 159.28 per share. | 09 Dec 2025 | 1,266 | 5,389 | - | 159.3 | 201,648 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 717 | 2,152 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 717 | 4,570 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 162.54 per share. | 01 Dec 2025 | 377 | 4,193 | - | 162.5 | 61,276 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2025 | 753 | 1,508 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2025 | 753 | 4,145 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 136.54 per share. | 29 Oct 2025 | 388 | 3,757 | - | 136.5 | 52,978 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 107.68 per share. | 30 Sep 2025 | 2,715 | 6,555 | - | 107.7 | 292,361 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 108.67 per share. | 30 Sep 2025 | 2,152 | 4,403 | - | 108.7 | 233,851 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.67 per share. | 30 Sep 2025 | 1,246 | 10,001 | - | 32.7 | 40,707 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2025 | 1,246 | 4,982 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 111.93 per share. | 30 Sep 2025 | 520 | 3,462 | - | 111.9 | 58,204 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 110.05 per share. | 30 Sep 2025 | 421 | 3,982 | - | 110.0 | 46,330 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 106.86 per share. | 30 Sep 2025 | 387 | 9,270 | - | 106.9 | 41,354 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 105.24 per share. | 30 Sep 2025 | 344 | 9,657 | - | 105.2 | 36,203 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 113.69 per share. | 30 Sep 2025 | 70 | 3,392 | - | 113.7 | 7,958 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2025 | 7,197 | 12,483 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2025 | 2,462 | 12,311 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2025 | 2,462 | 6,558 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 128.05 per share. | 09 Sep 2025 | 1,266 | 5,292 | - | 128.0 | 162,111 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 129.17 per share. | 09 Sep 2025 | 6 | 5,286 | - | 129.2 | 775 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2025 | 717 | 2,869 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2025 | 717 | 4,474 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 125.81 per share. | 01 Sep 2025 | 378 | 4,096 | - | 125.8 | 47,556 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jul 2025 | 753 | 2,261 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jul 2025 | 753 | 4,145 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 105.31 per share. | 29 Jul 2025 | 388 | 3,757 | - | 105.3 | 40,860 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 93.00 per share. | 09 Jul 2025 | 5,278 | 3,392 | - | 93 | 490,854 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 1,245 | 6,228 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.67 per share. | 09 Jul 2025 | 1,245 | 8,670 | - | 32.7 | 40,674 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 90.86 per share. | 01 Jul 2025 | 998 | 7,771 | - | 90.9 | 90,680 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 91.88 per share. | 01 Jul 2025 | 346 | 7,425 | - | 91.9 | 31,791 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2025 | 7,197 | 50,378 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2025 | 7,197 | 12,498 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 64.77 per share. | 16 Jun 2025 | 3,729 | 8,769 | - | 64.8 | 241,539 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 2,462 | 14,773 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 2,462 | 6,567 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 72.55 per share. | 09 Jun 2025 | 1,266 | 5,301 | - | 72.5 | 91,848 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2025 | 718 | 4,475 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2025 | 718 | 3,586 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 71.26 per share. | 01 Jun 2025 | 370 | 4,105 | - | 71.3 | 26,366 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2025 | 753 | 3,725 | - | 0 | Class A Common Stock |